regulatory
confidence high
sentiment neutral
materiality 0.60
Salarius Pharmaceuticals corrects false delisting reports; remains listed on Nasdaq
Decoy Therapeutics Inc.
- Company statement that stock continues trading on Nasdaq Capital Market under ticker SLRX despite inaccurate Yahoo Finance and CapIQ delisting reports.
- Nasdaq compliance regained: Bid Price Rule (Sep 4, 2025) and Equity Standard (Oct 10, 2025) re-attained.
- Merger with Decoy Therapeutics completed Nov 13, 2025; no delisting notification received from Nasdaq.
- Company contacted financial data platforms to correct erroneous delisting information.